Using molecular and biochemical assays, including RNA sequencing and pathway analysis, the research seeks to uncover the mechanisms through which YB1 influences NAFLD, with a particular focus on the inhibin beta E (INHBE)/TNF-β signaling pathway. This evidence concerns the gene YBX1 and metabolic dysfunction-associated steatotic liver disease.